Please login to the form below

Not currently logged in
Email:
Password:

medicines access

This page shows the latest medicines access news and features for those working in and with pharma, biotech and healthcare.

ABPI’s Aileen Thompson is crowned Healthcare Communiquétor 2018

ABPI’s Aileen Thompson is crowned Healthcare Communiquétor 2018

UK. Her day-to-day role however, includes securing industry and stakeholder partnership, ensuring that patients across the UK can access medicines.

Latest news

  • Vertex calls NHS England ‘outrageous’ as talks stall on Orkambi access Vertex calls NHS England ‘outrageous’ as talks stall on Orkambi access

    We find it unconscionable that the Government is unable to value the importance of these CF medicines and provide access. ... We stand ready to meet any time, any place, to ensure patient access to these life-changing and transformative medicines.

  • Pharma demands guarantees for UK sector deal Pharma demands guarantees for UK sector deal

    Pharma demands guarantees for UK sector deal. Ten companies warn of Brexit threat, and long-standing flaws in medicines access. ... Meanwhile Brexit still threatens to isolate the UK from the European Medicines Agency bloc, a move which would see it

  • UK pharma cheers EU science announcement UK pharma cheers EU science announcement

    a greater emphasis on ‘open science’predicated on free access to publications and data. ... supply of medicines so that patients in the UK and the EU are able to get access to medicines without problems or delays after the UK leaves the EU, ”she

  • Merck’s Brexit contingency plan? Stockpile medicines Merck’s Brexit contingency plan? Stockpile medicines

    Merck’ s Brexit contingency plan? Stockpile medicines. US pharma group MSD (Merck &Co in the US) has a dramatic back-up plan if Brexit goes awry – it is stockpiling supplies of ... MSD has stressed these are plans only and may not be implemented, but

  • Improving childhood cancer survival rates in developing countries Improving childhood cancer survival rates in developing countries

    At least 50% of these could be cured using generic World Health Organization-recommended essential medicines, but at least 80, 000 die unnecessarily without access to such therapy. ... There are worries around the lack of access to worldwide essential

More from news
Approximately 4 fully matching, plus 434 partially matching documents found.

Latest Intelligence

  • Indefinable, incomparable and enduring: the value of creativity Indefinable, incomparable and enduring: the value of creativity

    helping patients access innovative medicines.

  • ‘How is your day?’ ‘How is your day?’

    Secondly, building strong links between donor and patient communities to secure stable source plasma access. ... We encourage policymakers to cooperate with neighbouring countries to collect more plasma so patients everywhere will have better access to

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    a new model for proving efficacy and facilitating market access to new medicines. ... Mike Thompson told a Parliamentary committee last year he could see no upsides to Brexit: losing EMA membership, EU research funding and diminished access to scientific

  • Brexit Means Brexit Brexit Means Brexit

    Maintaining membership would, she said, assure a continuation of investment in innovative medicines in the UK. ... But it should also begin, privately at least, to stress the potential consumer impacts an alternative position might bring; the

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    But our approach and success also hinges on patients being able to access our medicines. ... But only 5% of patients in England can currently access these medicines routinely through the NHS.

More from intelligence
Approximately 0 fully matching, plus 74 partially matching documents found.

Latest appointments

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... During his time at Pfizer, Maine also

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    May’s new role will see her lead the biopharma’s commercial team in bringing Sobi ’s medicines to the country. ... She will also collaborate with the operations and patient access team to ensure the medicines are accessible to as many appropriate

  • Inceptua Medicines Access appoints senior new-hires Inceptua Medicines Access appoints senior new-hires

    Inceptua Medicines Access appoints senior new-hires. The new speciality business unit appoints senior project manager and office manager. ... Multipharma’s new speciality business unit, Inceptua has appointed Ruth Rostron as its new senior project

  • Multipharma launches Inceptua Medicines Access Multipharma launches Inceptua Medicines Access

    Multipharma launches Inceptua Medicines Access. The group will be split into three sub-divisions. ... Multipharma has launched Inceptua Medicines Access, a speciality business unit that offers access to pre-approval and unlicensed medicines.

  • Sandoz UK promotes Tim de Gavre to country head Sandoz UK promotes Tim de Gavre to country head

    As a company, Sandoz has an exciting portfolio of medicines and future product pipeline. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.

More from appointments
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    The goal is to try and accelerate access to these medicines by reducing the time taken to learn how to manufacture them. ... It would be nice to think that in the next ten to fifteen years, we’ ll see a pipeline of new medicines emerging off the back

  • Accession

    A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices. ... The early industry pioneers of market access, are the creative force behind Accession.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics